Endometrioma Clinical Trial
Official title:
Evaluate the Therapy of Large Ovarian Endometrioma
Endometrioma's prevalence is between 23 and 55%. It causes pelvic pain, decrease fertility and ovarian reserve. Currently, there's no recommendation about large endometrioma's treatment and there's no information on the best treatment to limit recurrences, preserve fertility and ovarian reserve. In Lille university hospital, simple laparoscopic drainage associated with hormonal therapy is practiced to reduce the risk of cystectomy. This protocol will be evaluated with an observational and prospective study, including women of childbearing age having endometrioma measuring 6 cm or above. The aim of this study is to assess if cyst drainage associated with GnRH agonist, could decrease endometrioma recurrences, deleterious effect on ovarian reserve and evaluate impact on anti-mullerian hormone
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01268930 -
Comparison of Hemostatic Matrix and Bipolar Coagulation in Surgical Treatment of Endometriomas
|
N/A | |
| Completed |
NCT05323539 -
Comparison of Thyroid Volumes in Patients With and Without Endometrioma
|
N/A | |
| Recruiting |
NCT04178876 -
Comparison of Laparoscopic Endometrioma Stripping Versus Ethanol Sclerotherapy( CLESS)
|
N/A | |
| Completed |
NCT06421857 -
Hemostatic Measures During Laparoscopic Cystectomy for Endometrioma
|
N/A | |
| Recruiting |
NCT04151433 -
Conservative Endometrioma Surgery
|
N/A | |
| Completed |
NCT01942122 -
DLBS1442 for The Treatment of Pain in Patients Suspected Endometriosis
|
Phase 2/Phase 3 | |
| Withdrawn |
NCT00999479 -
Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
|
N/A | |
| Recruiting |
NCT03687398 -
Genomic Maps of Endometrial Tissues of Patients With Endometriosis and Healthy Controls
|
||
| Not yet recruiting |
NCT06377553 -
PET/MRI for Evaluation of Endometriosis
|
||
| Not yet recruiting |
NCT03788720 -
Suture of the Ovary After Enucleation of Ovarian Endometrioma
|
N/A | |
| Completed |
NCT01982526 -
Role of Anti Mullerian Hormone for Ovarian Reserve Determination of Preoperative and Postoperative Endometrioma Patients
|
||
| Recruiting |
NCT05962775 -
Ethanol Sclerotherapy Prior to ART
|
N/A | |
| Completed |
NCT03484546 -
Optimum Menstrual Cycle Time for Endometrioma Excision
|
||
| Completed |
NCT01808170 -
Laparoscopic Ovarian Cystectomy of Endometrioma vs Deroofing and Ovarian Reserve
|
N/A | |
| Recruiting |
NCT05637073 -
Effect of Management of the Endometrioma on Ovarian Reserve
|
||
| Completed |
NCT06219044 -
Evaluation of Ovarian Reserve and Recurrence Rate After DWLS Diode Laser OMA Vaporization
|
N/A | |
| Recruiting |
NCT03620838 -
Endometrioma Per se Versus Treatment Related Reduction in Ovarian Reserve (ERROR-2 Trial)
|
||
| Terminated |
NCT03571776 -
Anti-mullerian Hormone (AMH) After Treatment of Endometriomas With Alcohol Sclerotherapy Versus Surgery: Clinical Trial
|
N/A | |
| Enrolling by invitation |
NCT02472873 -
Efficacy of Aspiration and Sclerotherapy During Laparoscopy Using 95% Ethanol for the Treatment of Endometriomas
|
N/A | |
| Completed |
NCT04941833 -
Desogestrel for the Preoperative Treatment of Endometrioma Compared With Placebo
|
Phase 2/Phase 3 |